|
||||||||||||||||||
![]() |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
![]() |
||||||||||||||||||
| Page 2 | Page 3 | Page 4 |
|
||||||||||||||||||
![]() |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
![]() |
||||||||||||||||||
| Page 2 | Page 3 | Page 4 |
Marc REISINGER, M.D. ( Presented at the European Methadone Association Forum, AMTA Methadone Conference, Phoenix, Arizona, October 31, 1995 ) European Methadone Association 27 rue de la Vanne 1050 Brussels, Belgium Tel + Fax : 322 640 46 28 [email protected] SUMMARY Methadone prescribing increased tenfold in the last four years in Belgium. This has been…
Methadone maintenance treatment has been the most effective treatment for addiction to heroin resulting the cessation of heroin use and criminal behavior. Prior to the development of methadone maintenance treatment over 28 years ago narcotic addiction was considered incurable and a behavioral disorder under the control of law enforcement. Drs. Dole and Nyswander brought the…
Medication Assisted Treatment (MAT) Advocacy The National Alliance for Medication Assisted Recovery (NAMA-R) holds the view that every individual who believes in Medication Assisted Treatment (MAT) is at least a potential Certified MAT Advocate (CMA). We encourage all supporters of MAT, patient and non-patient, to become Certified MAT Advocates so that all energies directed toward the advancement of…
Mechcatie, Elizabeth. Family Practice News 32(22): 7. November 15, 2002 The approval of the partial opioid agonist buprenorphine for treating opiate dependence has paved the way for office-based treatment of opioid addiction and far greater access to treatment for hundreds of thousands of heroin addicts across the country. Two sublingual formulations have been approved: Buprenorphine…
J. Thomas Payte, M.D. is Medical Director and Founder of Drug Dependence Associates in San Antonio, Texas, Chair of the Maintenance Medications Committee of the American Society of Addiction Medicine and a member of NAMAs Advisory Board. Jeffrey Smith, Ph.D. has a degree is central nervous system pharmacology. Joycelyn Woods, M.A. is President of NAMA….
From NIDDK Fact Sheet Chronic Hepatitis C: Current Disease Management “Strict abstinence from alcohol is recommended during therapy with interferon. Interferon therapy can be associated with relapse in people with a previous history of drug or alcohol abuse. Therefore, alpha interferon should be given with caution to a patient who has only recently stopped alcohol…